Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naltrexone in primary progressive multiple sclerosis
2005-005679-13Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of naltrexone in primary progressive multiple sclerosis (PPMS), sponsored by IRCCS Ospedale San Raffaele. Primary endpoints: Effect on spasticity, Effect on pain and 1 more. Started Jun 2006; status: completed.
02
Drugs
naltrexone
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on 2005-005679-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005679-13.